You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NAD-boosting drug

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19, Stage 1 Acute Kidney Injury Trial in Boston (MIB-626, Placebo, Home Treatment)

Recruiting
  • Covid19
  • Stage 1 Acute Kidney Injury
  • Boston, Massachusetts
    The Brigham and Women's Hospital
Nov 29, 2021

Systemic Lupus Erythematosus (Sle) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Nicotinamide Riboside)

Not yet recruiting
  • Systemic Lupus Erythematosus (Sle)
  • Nicotinamide Riboside
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 15, 2023

Hypertension Trial in London (Limitless)

Recruiting
  • Hypertension
  • Limitless
  • London, Ontario, Canada
    KGK Science Inc.
Mar 17, 2022

T2DM (Type 2 Diabetes) Trial in Bucheon (DWP16001 Amg)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • DWP16001 Amg
  • Bucheon, Korea, Republic of
    The Catholic University of Korea Bucheon St. Mary's Hospital, Re
Mar 30, 2022

Enhance Immune Function Trial (NMN)

Not yet recruiting
  • Enhance Immune Function
  • (no location specified)
Aug 2, 2023

NAD+/NADH in Peripheral Blood Samples of Different Gender and

Not yet recruiting
  • NAD+/NADH in Peripheral Blood Monitoring
  • Detection of NAD+/NADH concentration of Peripheral Blood Samples
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Aug 11, 2023

Covid19, Long COVID-19, Post-COVID-19 Syndrome Trial in Ann Arbor (Naltrexone, NAD+)

Completed
  • Covid19
  • +2 more
  • Ann Arbor, Michigan
    AgelessRx
Jan 23, 2023

Cancer Trial in Amsterdam, Nijmegen, Rotterdam (Olaparib, Cobicistat)

Recruiting
  • Cancer
  • Amsterdam, Netherlands
  • +2 more
Oct 21, 2022

Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)

Not yet recruiting
  • Type2diabetes
  • Diabetic Kidney Disease
  • Investigational Product - MIB 626
  • Placebo
  • (no location specified)
Mar 6, 2023

NSCLC Trial (Cobicistat)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Feb 17, 2023

SARS-CoV-2 Infection, Acute Kidney Injury Trial in New York, San Antonio, Seattle (Placebo, Nicotinamide riboside)

Active, not recruiting
  • SARS-CoV-2 Infection
  • Acute Kidney Injury
  • Placebo
  • Nicotinamide riboside
  • New York, New York
  • +3 more
Oct 25, 2022

Friedreich Ataxia Trial in Philadelphia (MIB-626)

Active, not recruiting
  • Friedreich Ataxia
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 26, 2022

Parkinson Disease, Neurodegenerative Diseases Trial in Bergen (Nicotinamide Riboside, Placebo)

Completed
  • Parkinson Disease
  • Neurodegenerative Diseases
  • Nicotinamide Riboside
  • Placebo
  • Bergen, Hordaland, Norway
    Haukeland University Hospital
Feb 10, 2020

Focal Onset Seizure, Focal Onset Epilepsy Trial in Worldwide (NBI-921352, Placebo)

Recruiting
  • Focal Onset Seizure
  • Focal Onset Epilepsy
  • Bruxelles, Belgium
  • +20 more
May 17, 2022

Vascular Diseases, Kidney Disease, Blood Pressure Trial in Aurora (Nicotinamide riboside)

Recruiting
  • Vascular Diseases
  • +3 more
  • Nicotinamide riboside
  • Aurora, Colorado
    UColorado
Jan 6, 2022

Cognitive Impairment, Sleep Quality Trial in Buffalo (Nicotinamide riboside, Placebo)

Not yet recruiting
  • Cognitive Impairment
  • Sleep Quality
  • Nicotinamide riboside
  • Placebo
  • Buffalo, New York
  • +1 more
Aug 10, 2022

Non Small Cell Lung Cancer Trial in Maastricht, Amsterdam (Cobicistat)

Completed
  • Non Small Cell Lung Cancer
  • Maastricht, Limburg, Netherlands
  • +1 more
Sep 23, 2022

Friedreich Ataxia 1 Trial in Philadelphia (Nicotinamide Riboside, Placebo, Exercise Intervention)

Recruiting
  • Friedreich Ataxia 1
  • Nicotinamide Riboside
  • +2 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Sep 21, 2022

Alzheimer's Disease (Incl Subtypes), Dementia Trial in Boston (MIB-626, Placebo)

Recruiting
  • Alzheimer's Disease (Incl Subtypes)
  • Dementia
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 11, 2022

Ketoses, Metabolic, Ketogenic Dieting, Alcohol Intoxication Trial in Philadelphia (dietary supplement, other, drug)

Not yet recruiting
  • Ketoses, Metabolic
  • +4 more
  • Ketone Supplement
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Center for Studies of Addiction
Sep 29, 2023

Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)

Not yet recruiting
  • Postoperative Prevention of Tumor
  • Oral NMN combined with DC cell vaccine
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Sep 6, 2023

Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)

Recruiting
  • Healthy
  • nicotinamide riboside
  • nicotinamide mononucleotide
  • Bergen, Vestland, Norway
    Haukeland University Hospital
Jan 25, 2023

Healthy Trial in Rwanda, United States (Ad26.Mos.HIV, Ad26.Mos4.HIV, Clade C gp140)

Completed
  • Healthy
  • Ad26.Mos.HIV
  • +3 more
  • Birmingham, Alabama
  • +9 more
Jul 5, 2022

Sarcopenia, Nicotinamide Adenine Dinucleotide Concentration, Muscle Quality and NAD+ Content Trial in Buffalo (Nicotinamide

Recruiting
  • Sarcopenia
  • +2 more
  • Nicotinamide Riboside
  • Placebo
  • Buffalo, New York
    VA Western New York Healthcare System, Buffalo, NY
Oct 19, 2021

Mitochondrial Health and Hemodynamic Instability Related to

Recruiting
  • Acute Kidney Injury (AKI)
    • Ottawa, Ont, Canada
      The Ottawa Hospital
    Feb 28, 2022